Global spinal non-fusion treatment market to hit $749M — 4 things to know

The global spinal non-fusion treatment market is expected to grow at a compound annual growth rate of 5.3 percent to $749 million by 2021, according to Wise Guy Reports’ research.

Advertisement

Here are four things to know:

 

1. The cervical total disc replacement market will drive the market’s growth, because of available clinical efficacy data and an increase in degenerative spine diseases.

 

2. The market will see increased activity in the mergers and acquisitions field.

 

3. DePuy Synthes, Medtronic, Aesculap, Alphatec Spine, Globus Medical, LDR, NuVasive, Paradigm Spine, RTI Surgical and Zimmer-Biomet lead the market.

 

4. More small- and medium-seized companies are now marketing their artificial disc and non-fusion technologies in the space.

 

More articles on devices:
Medtech, Life Spine, Zimmer Biomet & more: 20 key notes
Amedica’s product revenue drops 15% in 2015 to $19.5M: 7 key notes
Maxx Orthopedics’ Freedom PCK System successfully implanted in 1st surgeries: 4 points

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.